FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / formal-protest-filed.docx
formal-protest-filed.docx · 1018-00009

Parties

Harkness LLP
Penterra Pharmaceuticals Corp
APPEALS CONFERENCE Penterra Pharmaceuticals Corp
Penterra Manufacturing Ireland Ltd
Associates LLP
Harborview Corp
Altera Corp
Whitmore Valuation Group LLC

Dates

October 12, 2023
November 8, 2023
December 22, 2023
June 8, 2022
December 31, 2017
December 31, 2018
December 31, 2019
December 31, 2020
March 15, 2012
July 1, 2012

Amounts

$380,400,000
$15,977,000
$6.82
$1.47
$3.12
$1.34
$1.87
$0.79
$0.62
$0.28

Obligations

482-1(d) establishes the "best method rule," which provides that the arm's-length result of a controlled transaction must be determined under the method that, under the facts and circumstances, provides the most reliable measure of an arm's-length result
482-7(b), a QCSA must meet the following requirements: (i) two or more controlled participants must join in the arrangement; (ii) each participant must have a reasonable expectation of deriving benefits from the cost-shared intangibles; (iii) each participant must bear a share of the intangible development costs ("Coss") that is consistent with its share of reasonably anticipated benefits ("RABs"); and (iv) the arrangement must be documented contemporaneously
482-7(e) provides that each controlled participant's share of coss must be proportionate to its share of RABs from the exploitation of cost-shared intangibles
The RAB shares must be determined on a basis that is consistent and reasonable across all participants
When a controlled participant contributes pre-existing resources, capabilities, or rights to the CSA, a platform contribution transaction ("PCT") is required to compensate the other participants for the value contributed
person transfers intangible property to a foreign corporation in certain transactions described in IRC § 332, 351, 354, 356, or 361, the transferor shall be treated as having sold such intangible property in exchange for payments contingent on the productivity, use, or disposition of the property